Vikrama Pharma Industries Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 4 Year, 27 Days
- Last Filing with ROC 31 Mar 2024
About Vikrama Pharma Industries
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Panyam Madhuri and Rajeev Panyam serve as directors at the Company.
- CIN/LLPIN
U24303TG2020PTC146346
- Company No.
146346
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 2020
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vikrama Pharma Industries?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Panyam Madhuri  | Director | 27-Nov-2020 | Current |
| Rajeev Panyam | Director | 27-Nov-2020 | Current |
Financial Performance of Vikrama Pharma Industries.
Enhance accessibility to Vikrama Pharma Industries's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vikrama Pharma Industries?
Unlock access to Vikrama Pharma Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vibrama Textiles Private LimitedActive 4 years 29 daysPanyam Madhuri and Rajeev Panyam are mutual person
- Vibrama Health Care Private LimitedActive 4 years 29 days
Panyam Madhuri and Rajeev Panyam are mutual person
- Vibrama Entertainments Private LimitedActive 4 years 27 days
Panyam Madhuri and Rajeev Panyam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vikrama Pharma Industries?
Vikrama Pharma Industries has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vikrama Pharma Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vikrama Pharma Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
